ABSTRACT
Background: The minimally invasive surgery maintained the advantages while total mesorectal excision treatments for the rectal cancer are made simpler using the advanced robotic technologies.
Objective: To comparison to the traditional laparoscopic surgery, and robotic surgery for the rectal cancer results in reduced rates of conversion and a quicker return of urogenital function. However, the main drawbacks of robotic surgery are the prolonged operation time and exorbitant cost.
Results: In comparison to laparoscopic surgery, mostly other short-term surgical results, the pathologic outcomes, and the long-term oncologic outcomes of robotic surgery have not yet demonstrated any appreciable improvements. However, because it significantly lessens the burden and learning curve for the surgeon, robotic surgery is still a viable and eagerly awaited surgical method for the rectal cancer. Additionally, there are benefits when using robotic techniques for intricate surgeries like intersphincteric excision or lateral pelvic lymph node dissection.
Conclusion: It is anticipated that the advent of the new surgical robot systems, such as da Vinci® SP system, would broaden the uses of robotic surgery and offer additional benefits.